GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED – Trademark Portfolio

Entity Type: 22

GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include WARKLMA. The owner is based in GUANGZHOU.

227M, FLOOR 2, NO.846 SANYUANLI AVENUE,

BAIYUN DISTRICT

GUANGZHOU , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WARKLMA
WARKLMA
Registered 2020

Trademark Classifications

GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED have?

GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED file in?

GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED's most well-known trademarks?

GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED's registered trademark portfolio includes well-known marks such as WARKLMA. These are among 1 currently registered trademark in the portfolio.

What is GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED's trademark registration success rate?

GUANGZHOU ZIMI NETWORK TECHNOLOGY CO., LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.